NewsBenzingaEikon Therapeutics Presents Initial And Updated Data For EIK1003 And Initial Data For EIK1004 And EIK1005 At ESMO 2026; Initial And Updated Cohort Data From Ongoing Phase 1/2 Study Of EIK1003 Continue To Support Potentially Differentiated Profile Eikon Therapeutics Presents Initial And Updated Data For EIK1003 And Initial Data For EIK1004 And EIK1005 At ESMO 2026; Initial And Updated Cohort Data From Ongoing Phase 1/2 Study Of EIK1003 Continue To Support Potentially Differentiated Profile Benzinga 2026.10.23 13:23 (GMT+0) Open on Benzinga Other news Openai CEO Sam Altman Says AI Revolution Without Ex-Nvidia CEO Huang Is ‘Hard To Imagine’ SpaceX Stock to Double? Analyst Says Company Completed ‘The Missing Piece of the Reusability Puzzle’ What Is Going on With Supermicro Stock on Monday? Bernie Sanders Tells Big Tech Their $3 Trillion in AI Debt Rides on a 'High-Stakes Gamble' — If It Fails, 'Don't Come Begging to Taxpayers' Global Mofy Stock Nearly Triples as Investors Eye Its Latest AI Investment Intercontinental Exchange And Abra Partner On Digital Asset Custody For Institutional Loans And Digital Asset Investment Strategies
Bernie Sanders Tells Big Tech Their $3 Trillion in AI Debt Rides on a 'High-Stakes Gamble' — If It Fails, 'Don't Come Begging to Taxpayers'
Intercontinental Exchange And Abra Partner On Digital Asset Custody For Institutional Loans And Digital Asset Investment Strategies